NCT03375385View on ClinicalTrials.gov

Dexmedetomidine Versus Propofol for Sedation in Stereotactic Brain Biopsy

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Adverse Effects in the Therapeutic Use of Other and Unspecified Agents Primarily Acting on the Respiratory System
Interventions
DRUG

dexmedetomidine/ propofol

The loading and infusion doses of dexmedetomidine hydrochloride and 1% propofol were calculated according to the patient's body weight and diluted to a 10 ml volume (labeled as loading-1 and loading-2) and a 50 ml volume (labeled as infusion-1 and infusion-2).

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03375385 - Dexmedetomidine Versus Propofol for Sedation in Stereotactic Brain Biopsy | Biotech Hunter | Biotech Hunter